MCM
GILD icon

Marsico Capital Management’s Gilead Sciences GILD Stock Holding History

Marsico Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-2,699,926
Closed -$265M – 94
2015
Q1 		$265M Sell
2,699,926
-3,403,177
-56% -$346M 2.23% 16
2014
Q4 		$575M Sell
6,103,103
-3,082,858
-34% -$319M 4.62% 4
2014
Q3 		$978M Sell
9,185,961
-1,363,172
-13% -$133M 7.65% 1
2014
Q2 		$875M Sell
10,549,133
-574,990
-5% -$44.8M 6.34% 1
2014
Q1 		$788M Sell
11,124,123
-1,800,149
-14% -$141M 5.69% 2
2013
Q4 		$971M Buy
12,924,272
+757,544
+6% +$52.7M 6.88% 1
2013
Q3 		$765M Sell
12,166,728
-4,874,616
-29% -$291M 5.65% 1
2013
Q2 		$873M Buy
+17,041,344
New +$888M 5.48% 1

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Marsico Capital Management's GILD Position: Q2 2015 in Review

Marsico Capital Management sold out of Gilead Sciences (GILD) in Q2 2015, closing a stake of 2,699,926 shares — an estimated $265M sold.

Marsico Capital Management first reported a position in GILD in Q2 2013 and held it in 8 quarters. The position peaked at $978M in Q3 2014. 1,561 funds tracked by Wall St. Rank hold GILD as of Q2 2015.

  • Marsico Capital Management reported no remaining Gilead Sciences position as of Q2 2015 after selling out during the quarter.
  • Marsico Capital Management sold 2,699,926 Gilead Sciences shares in Q2 2015, an estimated $265M.
  • Marsico Capital Management first reported a position in Gilead Sciences in Q2 2013 and held it in 8 quarters.
  • Marsico Capital Management's Gilead Sciences position peaked at $978M in Q3 2014.
  • 1,561 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2015.

Based on Marsico Capital Management's 13F filing for Q2 2015, filed 13 Aug 2015.